Infant CD4 C868T polymorphism is associated with increased human immunodeficiency virus (HIV-1) acquisition

No prior work had resolved whether specific genetic variations in the CD4 receptor influence vertical viral transmission rates. It was already known that the CD4 molecule serves as the primary entry point for the virus into host cells. That uncertainty drove interest in how structural changes might alter viral binding or entry efficiency. Prior research has shown that single nucleotide polymorphisms can significantly impact immune response and disease progression. This gap motivated an investigation into the C868T variant in a high-risk pediatric population. Scientists have long suspected that host genetics play a role in differential susceptibility to infection. Previous observations in adult cohorts suggested a potential link between this polymorphism and viral acquisition. This study builds upon those foundations to clarify the role of this genetic marker in infants.

The aim of this research was to determine if the C868T genetic variation in the CD4 receptor influences the risk of vertical viral transmission. Scientists sought to understand whether this specific amino acid change alters the structural properties of the receptor. The investigation focused on whether such modifications could facilitate easier viral entry into infant cells. This study addresses the gap in understanding how host genetics impact pediatric infection susceptibility. The team was motivated by earlier reports suggesting a link between this polymorphism and increased viral acquisition in adults. By following a cohort of infants born to infected mothers, the researchers intended to quantify the impact of this allele on transmission outcomes. They specifically examined whether the 868T variant remains a significant risk factor after controlling for maternal viral load. This work provides a clearer picture of the genetic determinants involved in mother-to-child infection pathways.

The team conducted a prospective observational study following pregnant women and their offspring for one year. Investigators recruited participants from Nairobi to monitor vertical transmission outcomes in a high-prevalence environment. Clinical staff collected blood samples to determine the genetic status of each infant at the 868 position. Researchers employed statistical modeling to calculate hazard ratios for viral acquisition among different genotype groups. The approach involved adjusting for maternal viral load to isolate the effect of the infant genotype. Laboratory personnel performed genotyping to identify the presence of the T allele versus the wild-type sequence. This design allowed for the systematic comparison of infection rates across the study population. The analysis focused on evaluating how this specific receptor change correlates with clinical infection events over time.

Infants carrying the 868T allele exhibited a significantly higher likelihood of acquiring the virus compared to those with the wild-type genotype. The study reported an overall hazard ratio of 1.92 for infection among carriers of the variant. After adjusting for maternal viral load, the hazard ratio increased to 2.03, confirming a strong statistical association. The 95% confidence interval for the adjusted hazard ratio ranged from 1.03 to 3.98, with a p-value of 0.04. These results indicate that the genetic variant is linked to increased susceptibility to mother-to-child transmission. The allele frequency within the studied cohort was approximately 15 percent. This finding mirrors patterns observed in previous research involving adult cohorts in the same geographic region. The data suggest that this specific genetic marker contributes to the risk of vertical viral acquisition.

The authors propose that the 868T allele serves as a genetic marker for heightened vulnerability to vertical viral transmission. Their data suggest that infants possessing this variant face a nearly twofold increase in acquisition risk. These findings align with earlier reports identifying similar susceptibility patterns among adult cohorts in the same region. The researchers emphasize that this genetic factor remains significant even after accounting for maternal viral load levels. This synthesis implies that host genotype contributes to the complex dynamics of mother-to-child infection pathways. The team highlights the importance of considering genetic diversity when evaluating pediatric health outcomes in high-prevalence settings. Their results provide evidence that this specific polymorphism influences the likelihood of infection during the perinatal period. This work underscores the necessity of integrating genetic screening into broader models of viral transmission risk.